NCT03750500

Brief Summary

This study is a single-center, prospective, non-blind, parallel-group, randomized controlled trial with an experimental and a control group with the aim of evaluating the clinical impact of a home-based falls prevention program using a new biofeedback system on community-dwellers older adults with fall risk in comparison with standard of care. The experimental group will perform a 12-week exercise program at home, under remote monitoring from a clinical team, whereas the control group will benefit from standard medical care currently in place at the participating primary care facility. The hypothesis is that the home-based falls prevention program will lead to a lower risk of falling than standard medical care.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
6mo left

Started May 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
May 2025Nov 2026

First Submitted

Initial submission to the registry

November 20, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 23, 2018

Completed
6.4 years until next milestone

Study Start

First participant enrolled

May 1, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

December 6, 2024

Status Verified

December 1, 2024

Enrollment Period

1.3 years

First QC Date

November 20, 2018

Last Update Submit

December 4, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in the 5 Times Sit to Stand Test

    The 5 Times Sit to Stand Test is a performance test that measures the strength and the lower limb mobility. It consists of the time it takes to stand up from a chair five consecutive times. A cutoff value of 15 seconds is used to distinguish between individuals with and without risk of recurrent falls

    Baseline; week 4; week 8; week 12 and then week 24

Secondary Outcomes (3)

  • Change in the Timed Up and Go Test score

    Baseline; week 4; week 8; week 12 and then week 24

  • Change in the Berg Balance Scale

    Baseline; week 4; week 8; week 12 and then week 24

  • Change in the Shorts Falls Efficacy Scale-International

    Baseline; week 4; week 8; week 12 and then week 24

Study Arms (2)

Experimental

EXPERIMENTAL

Participants included in this arm will benefit from a 12-week exercise program using the novel biofeedback rehabilitation device, under remote monitoring from a physical therapist

Device: Biofeedback deviceBehavioral: Education on falls riskOther: Medication reviewDiagnostic Test: Visual and auditory screening

Standard of Care

PLACEBO COMPARATOR

Patients included in this arm will benefit from the standard of care currently in place in the Primary Care facility: education on risk factors for falls, medication review, visual and auditory acuity screening.

Behavioral: Education on falls riskOther: Medication reviewDiagnostic Test: Visual and auditory screening

Interventions

12-week exercise program performed through the device

Also known as: SWORD Phoenix
Experimental

Education on falls risk factors and how to minimize them

ExperimentalStandard of Care

Medication will be reviewed to reduce sedative drugs and minimize interactions

ExperimentalStandard of Care

Patients will go through visual and auditory screening as part of their regular care

ExperimentalStandard of Care

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Patients aged over 65 years old
  • Ability to walk at least 20 meters, unaided or with unilateral support
  • Ability to understand motor complex commands
  • Mini-Mental State Examination (MMSE) score \> 24 points
  • Functional independence for instrumental activities of daily living
  • Risk of recurrent falls, defined as 5xSST score \> 15,00 seconds

You may not qualify if:

  • Patients residing in nursing homes, daycare units or assisted-living facilities
  • Aphasia, dementia or psychiatric comorbidity, significantly interfering with communication or compliance with a home-based exercise program
  • Severe visual our hearing, interfering with communication or with compliance to a home-based exercise program
  • Cardiac, respiratory or other condition incompatible with at least 30 minutes of light to moderate physical activity
  • Osteoarticular conditions (e.g. severe osteoarthrosis), which prevent the patient from complying with a home-based exercise program
  • Patients with neurologic conditions (e.g. stroke, multiple sclerosis, Parkinson's disease)
  • Other medical complications, which prevent the patient from complying with a home-based exercise program
  • Illiteracy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

USF Aldoar

Porto, Portugal

Location

MeSH Terms

Interventions

Medication Review

Intervention Hierarchy (Ancestors)

Medication SystemsOrganization and AdministrationHealth Services AdministrationPatient Care Management

Central Study Contacts

Fernando Correia, MD

CONTACT

Mariana Sant'Ana, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 20, 2018

First Posted

November 23, 2018

Study Start

May 1, 2025

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

December 6, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

Study protocol and study aggregate results (including anonymised individual patient data) will be made available

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
The data will become available upon study publication, for 5 years.
Access Criteria
The protocol will be made available through this platform.

Locations